// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























387 Abstracts

AN ENIGMATIC DIAGNOSIS: PROSTHETIC VALVE ENDOCARDITIS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT

John Davis - American College of Cardiology (ACC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Prosthetic valve endocarditis

furosemide GR

A PRESENTATION OF DELAYED MYOCARDITIS AFTER CORONAVIRUS DISEASE-2019

Tatiana Echeverry - American College of Cardiology (ACC) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Arrhythmia

Icosapent ethyl

CLINICAL EFFECTS OF STANDARD AND INDIVIDUALIZED DIALYSATE SODIUM IN PATIENTS ON CHRONIC HEMODIALYSIS.

M. DOSHI - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Fatty Acid Length Dictates Association of Sphingomyelins With Sudden Cardiac Death

Lee Bockus - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Palmitic acid

Clinical Utility of Machine Learning-Derived Vocal-Biomarker in the Management of Heart Failure

Kozo Okada - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

N/A

Geriatric Nutritional Risk Index Predicts Bleeding Event in Patients With Heart Failure

Yu Sato - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Gastrointestinal bleeding

N/A

Persistent Hypochloremia is Associated With Adverse Prognosis in Patients With Heart Failure

Yuji Nozaki - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Comparison of Transthyretin Amyloid Cardiomyopathy Patients Taking Tafamidis and Those Not Taking Tafamidis Using Two-Dimensional Speckle Tracking Echocardiography

Fumi Oike - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Transthyretin cardiac amyloidosis

Tafamidis meglumine

SAFETY AND EFFICACY OF DPP4 INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: A BIOMARKER DRIVEN DOUBLE-BLINDED RANDOMIZED CONTROLLED TRIAL

Paulo Rizzo Genestreti - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Sitagliptin

SEVERE RHEUMATIC MIXED MITRAL VALVE DISEASE IN PREGNANCY

Jessica Parr - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Mitral valve disease

N/A

The effect of Mediterranean diet or mindfulness-based stress reduction on fetal cardiac remodelling in small for gestational age: the IMPACT-BCN trial

L. Youssef - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Predictive Value of Routine Biomarkers for Adverse Clinical Outcomes After Transcatheter Aortic Valve Replacement (TAVR)

Kris Atema - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Objective Functional Improvement After TAVR: Prognostic Implications and Development of an Integrative Predictive Model

Jose de la Torre Hernandez - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Interactions of circulating, digoxin-like, steroids with rate control therapy for atrial fibrillation in the rate-af randomised controlled trial

Ioannis Akoumianakis - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Digoxin

Relation between N-terminal pro B-type natriuretic peptide (NT-probnp) and disease severity in paediatric hypertrophic cardiomyopathy

Laxmi Kaliyappan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

N/A

Hospital admissions in the last year of life in patients with heart failure

Alexandra Abel - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart failure with reduced ejection fraction

N/A

Limitations of Established Cardiac Biomarkers in Low-to Intermediate-Risk TF-TAVR Patients With Advanced CKD

Hatim Seoudy - Transcatheter Cardiovascular Therapeutics (TCT) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Severe Aortic Stenosis

N/A

Impact of Diastolic Dysfunction on Mortality and Quality of Life After Transcatheter Aortic Valve Replacement

Mahesh Anantha Narayanan - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Diastolic dysfunction

N/A

Prognostic Value of the Index of Microcirculatory Resistance Over Serum Biomarkers in Light Chain Cardiac Amyloidosis

Joo Myung Lee - Transcatheter Cardiovascular Therapeutics (TCT) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

AL Amyloidosis

N/A

Coronary Microvascular Dysfunction in Takotsubo Cardiomyopathy Assessed by Angiography-Derived Index of Microcirculatory Resistance, a Pressure Wire–Free Tool

Estefanía Fernández Peregrina - Transcatheter Cardiovascular Therapeutics (TCT) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Microvascular dysfunction

N/A

Copyright © 2026. QuantiNova All rights reserved